There are several critical questions that your internal team should be ready to address when preparing product portfolios and seeking out a CRO.
Artificial intelligence and machine learning technologies have significant potential, but regulatory hurdles may stand in their way.
Health technology developers need to prioritize security from the moment a device or platform is first incepted.
Class I device manufacturers need to keep on top of new classification rules to avoid loss of market share under the close approaching EU MDR deadline.
A timely step toward ensuring patient safety through data-driven product development.
The technology can prevent ongoing tissue damage and degeneration before an issue becomes too large to fix.
Integrity is what matters most, and it just makes good business sense.
Going paperless is easier than you think.
In addition, in workforce optimization, retention plays an equally important role as recruitment.
Pharmaceutical companies have long been subject to the kinds of rigorous electronic reporting standards that will soon affect medical device manufacturers. What can be gleaned from their experiences?